HearingAssist Eaze vs Resound Vivia 9 60S microRIE

The HearingAssist Eaze is a budget-priced OTC hearing aid released in 2023, earning a B grade with a SoundScore of 3.4/5 in our lab testing. At $399, it sits in the most affordable price tier of the OTC market, though it ranks #43 of 65 devices in its category. In our standardized testing, the Eaze demonstrates excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling during typical daily activities. However, the device shows limitations in other areas: speech clarity scores are mixed at 2.6/5 in quiet and low at 1.3/5 in noisy environments, both falling slightly below category averages. The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average. Buyers who prioritize phone streaming for music or media should consider alternatives. Own-voice comfort is also mixed at 2.2/5, approximately 0.31 points below average for OTC devices. At this price point, shoppers have several higher-scoring alternatives to consider, including the Elehear Beyond and Apple AirPods Pro 2, which offer stronger overall performance. The HearingAssist Eaze may suit budget-conscious buyers who prioritize feedback stability over streaming capabilities and can accept modest speech performance in challenging listening situations.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.